A 2026 State-of-the-Art review updates the ABCs of cardiovascular disease prevention to help clinicians apply contemporary risk assessment, lifestyle, pharmacologic, and cardiometabolic strategies in ...
The U.S. SGLT2 Inhibitors Market is projected to grow from USD 5.49 Billion in 2025 to USD 11.06 Billion by 2035, while ...
A new Kimberley-based study is helping Aboriginal people living with diabetes-related foot disease (DFD) by identifying ways ...
A research team at The Hong Kong Polytechnic University (PolyU) has developed Hong Kong's first "AI Agent for Precision Diabetes Management—PIPE-AI" (AI Agent), designed specifically for Asian ...
Type 2 diabetes (T2D) is closely associated with chronic low-grade inflammation and immune-mediated metabolic dysfunction. Increasing evidence highlights ...
Asthma is the most common chronic airway disease worldwide, imposing substantial clinical, societal, and economic burden.
Eligibility estimates contract from ~13.3 million with obesity/overweight to ~3.8 million Bridge-eligible Part D enrollees after excluding diabetes, OSA, MASH, and current GLP‑1 users. Modeled ...
Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, ...
Objective To investigate the association between attention-deficit/hyperactivity disorder (ADHD) and cardiometabolic risk profile at the time of type 2 diabetes (T2D) diagnosis and examine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results